| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| The Johns Hopkins Ovarian Cancer Center of Excellence acknowledges and thanks Aventis, Genzyme, GlaxoSmithKline, Oncotech, Ortho Biotech, and The Pam McDonald Fund for their support of this website through provision of unrestricted educational grants. |
|
 |
|
 |
| Group: |
Treatment |
| Message Title: |
thank-you
|
| Posted By: |
barbara
|
| Date Posted: |
December 05, 2005
|
|
Message Body:
I want to thank Hedy and Karol for their helpful and encouraging responses to my message regarding IP Chemotherapy. I am happy to report that my last treatment will be on Dec. 13, if all goes as planned, and I can really see the end of chemo in sight.
A very thankful camper,
Barbara
|
If you wish to reply to this message, you must be a registered member* of this site. Please take a
moment to log in or to sign up for a membership.
* The Ovarian Cancer Survivor Network is a service to ovarian cancer
patients at Johns Hopkins and Franklin Square Center, thus membership is restricted to only these patients.
If you are not a Hopkins or Franklin Square ovarian cancer patient, you can view but not post messages to
the Network.
|
|
